CEREVEL THERAPEUTICS HLDNG I

CUSIP: 15678U128 Class: Common Stock

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 291,457 Value ($000) $11,918 Avg Close — Range —
Q1 2024
Shares 305,541 Value ($000) $12,915 Avg Close — Range —
Q4 2023
Shares 218,120 Value ($000) $9,248 Avg Close — Range —
Q3 2023
Shares 127,657 Value ($000) $2,787 Avg Close — Range —
Q2 2023
Shares 101,058 Value ($000) $3,213 Avg Close — Range —
Q1 2023
Shares 122,975 Value ($000) $2,999 Avg Close — Range —
Q4 2022
Shares 114,438 Value ($000) $3,609 Avg Close — Range —
Q3 2022
Shares 19,081 Value ($000) $539 Avg Close — Range —
Q2 2022
Shares 52,424 Value ($000) $1,387 Avg Close — Range —
Q1 2022
Shares 36,895 Value ($000) $1,291 Avg Close — Range —
Q4 2021
Shares 211,382 Value ($000) $6,853 Avg Close — Range —
Q3 2021
Shares 8,220 Value ($000) $243 Avg Close — Range —
Q2 2021
Shares 6,500 Value ($000) $167 Avg Close — Range —
Q1 2021
Shares 8,403 Value ($000) $115 Avg Close — Range —
Q4 2020
Shares 13,372 Value ($000) $222 Avg Close — Range —